Diagnamed Holdings Corp.
Diagnamed Holdings Corp. (DMED.CN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
dmed.cn · pe ratio · data through Sep 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Diagnamed Holdings Corp. (DMED.CN) measures how much investors pay for each dollar of the company's trailing earnings. DMED.CN's current PE ratio of N/A is calculated by dividing its stock price of $0.05 by its TTM earnings per share of -$0.01.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-09-30
PE Ratio History
2021 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Diagnamed Holdings Corp.You DMED.CN | $5M | N/A | — | -$0.01 |
 AI/ML Innovations Inc. AIML.CN | $8M | N/A | — | -$0.03 |
 Avant Brands Inc. AVNT.TO | $7M | N/A | — | -$0.88 |
 Ayurcann Holdings Corp. AYUR.CN | $2M | N/A | — | -$0.02 |
 BioVaxys Technology Corp. BIOV.CN | $2M | N/A | — | -$0.20 |
 CLS Holdings USA, Inc. CLSH.CN | $8M | N/A | — | -$0.05 |
 Crescita Therapeutics Inc. CTX.TO | $15M | N/A | — | -$0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-09-30Latest FY2025 | — | $-0.02 | — | |
2024-09-30 FY2024 | — | $-0.01 | — | |
2023-09-30 FY2023 | — | $-0.02 | — | |
2022-09-30 FY2022 | — | $-0.01 | — | |
2021-09-30 FY2021 | — | $-0.03 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Diagnamed Holdings Corp. (DMED.CN) measures how much investors pay for each dollar of the company's trailing earnings. DMED.CN's current PE ratio of N/A is calculated by dividing its stock price of $0.05 by its TTM earnings per share of -$0.01.
Frequently asked questions
DMED.CN pe ratio · 6 questionsDMED.CN's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.05 and TTM EPS of -$0.01. Data sourced from Financial Modeling Prep via DMED.CN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Diagnamed Holdings Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09